Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#199 most reported symptom for this vaccine
Blood magnesium increased has been reported 5 times in association with Influenza, Seasonal (Flucelvax) vaccination in VAERS. This represents 0.3% of all 1,689 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 5 involved hospitalization (100.0%).
Blood magnesium increased is the #199 most frequently reported symptom for Influenza, Seasonal (Flucelvax) out of 394 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 5 reports of Blood magnesium increased after Influenza, Seasonal (Flucelvax) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.